ArticleJournal of hematology & oncology2026

Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants.

Pao-Yen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.